There are many groups of women with anovulatory infertility who respond abnormally to
conventional treatment. It is important to diagnose the underlying disorder correctly before …

The paper by Rojas (1995) that introduces the debate on the effects of ovulation induction
with gonadotrophins is far reaching in both its coverage of the subject and its concerns …

Recent methods for induction of ovulation in the woman are described. The only indication
for use of these medications is induction of ovulation and pregnancy. In properly selected …

A total of 82 normogonadotrophic clomiphene-resistant anovulatory patients were treated
with exogenous gonadotrophins according to a step-down dose regimen during 234 cycles …

Seventy-three treatment courses of pulsatile gonadotropin-releasing hormone (GnRH) were
given to 19 patients with clomiphene nonresponsive anovulatory infertility. Fifty cycles were …

It is uncertain whether patients who do not ovulate but fail to conceive following CC therapy
behave differently during gonadotropin therapy. However, if the infertile patient with PCOS is …

Gonadotropin-releasing hormone (0.025 μg/kg) was administered intravenously in a
pulsatile fashion to four subjects with polycystic ovary syndrome for a total of six cycles. Five …

This chapter has focused on the step-down principle for gonadotrophin induction of
ovulation in women suffering from clomiphene-resistant anovulation. The physiological …

The use of pulsatile GnRH to treat infertile women who do not ovulate has been shown to be
safe, simple, and effective and the preferred method of inducing ovulation in appropriately …

Gonadotropins are released in a pulsatile fashion at a frequency of between 1 and 2 hours
in the follicular phase of the menstrual cycle. Human menopausal gonadotropins are usually …